With the global IVD market at USD 93.56 billion in 2023 and forecast to reach USD 125.3 billion by 2030 at a 3.9% CAGR, competitive pressure is rising across diagnostics, from analyzers and reagents to lab services and next generation sequencing. Roche holds 18.5% of the global IVD market, while Illumina leads NGS diagnostics with 52.3% share in 2023, and that split of dominance across test types is only the beginning. Let’s connect these brand level stakes and growth rates to what they mean for clinical workflows and where the next wave of testing capacity is likely to land.
Key Takeaways
- Roche Diagnostics held 18.5% market share in the global IVD market in 2023
- Abbott Laboratories commanded 14.2% share of the U.S. diagnostics market in 2022
- Siemens Healthineers accounted for 12.8% of the global immunoassay analyzers market in 2023
- The global in vitro diagnostics (IVD) market size was valued at USD 93.56 billion in 2023 and is expected to grow at a CAGR of 3.9% from 2024 to 2030
- The U.S. diagnostic imaging market was valued at USD 50.2 billion in 2022 and is projected to reach USD 63.5 billion by 2030, growing at a CAGR of 3.1%
- North America held a 41.2% share of the global IVD market in 2023, driven by advanced healthcare infrastructure
- North America dominated the IVD market with 41% share in 2023 due to high adoption rates
- Asia-Pacific IVD market grew fastest at 6.7% CAGR from 2023-2030, driven by China and India
- Europe held 30% of global diagnostic imaging market in 2023, led by Germany and UK
- The adoption of AI in diagnostic imaging reached 25% of U.S. hospitals by 2023, improving accuracy by 15-20%
- Next-generation sequencing (NGS) throughput increased 100-fold from 2015 to 2023, enabling whole-genome sequencing under USD 600
- Point-of-care ultrasound devices reduced diagnostic time by 40% in emergency settings as per 2022 studies
- The IVD market is projected to reach USD 125.3 billion by 2030 at 3.9% CAGR amid rising chronic diseases
- Point-of-care diagnostics expected to grow to USD 68.7 billion by 2030, driven by home testing kits, CAGR 5.7%
- Molecular diagnostics market forecasted at USD 32.4 billion by 2030, CAGR 10.2% due to NGS and PCR advances
In 2023, North America led IVD growth while major brands like Roche and Abbott dominated market share.
Related reading
02 · Category
Market Size & Growth30 stats
01
The global in vitro diagnostics (IVD) market size was valued at USD 93.56 billion in 2023 and is expected to grow at a CAGR of 3.9% from 2024 to 2030
02
The U.S. diagnostic imaging market was valued at USD 50.2 billion in 2022 and is projected to reach USD 63.5 billion by 2030, growing at a CAGR of 3.1%
03
North America held a 41.2% share of the global IVD market in 2023, driven by advanced healthcare infrastructure
04
The molecular diagnostics segment of the IVD market is anticipated to grow at a CAGR of 10.2% from 2023 to 2028
05
Global point-of-care diagnostics market size reached USD 44.1 billion in 2022 and is forecasted to hit USD 68.7 billion by 2030 at a CAGR of 5.7%
06
Europe IVD market accounted for USD 28.4 billion in 2023 with a projected CAGR of 4.1% through 2030
07
The clinical chemistry analyzers market was valued at USD 12.9 billion in 2022 and expected to grow to USD 18.2 billion by 2030, CAGR 4.4%
08
Asia-Pacific diagnostic labs market size was USD 25.6 billion in 2023, projected CAGR of 7.8% to 2032
09
Global lab automation market reached USD 5.2 billion in 2023, expected to grow at 7.1% CAGR to USD 8.9 billion by 2030
10
U.S. clinical laboratory services market valued at USD 102.4 billion in 2022, CAGR 5.2% to USD 162.3 billion by 2032
11
The immunoassay analyzers market size was USD 26.8 billion in 2023, projected to reach USD 38.4 billion by 2030 at 5.2% CAGR
12
Global hematology analyzers and reagents market hit USD 4.5 billion in 2022, growing to USD 6.8 billion by 2030, CAGR 5.3%
13
Diagnostic imaging equipment market in India valued at USD 1.2 billion in 2023, CAGR 8.5% to 2030
14
Worldwide PCR technologies market size was USD 13.8 billion in 2023, expected CAGR 8.4% to USD 24.3 billion by 2032
15
The tissue diagnostics market reached USD 5.9 billion in 2023, projected to USD 9.2 billion by 2030, CAGR 6.5%
16
Global glucose monitoring devices market valued at USD 12.1 billion in 2022, CAGR 7.9% to USD 22.4 billion by 2030
17
U.S. molecular diagnostics market size was USD 11.5 billion in 2023, growing at 9.2% CAGR to 2030
18
The flow cytometry market hit USD 5.1 billion in 2022, expected to reach USD 9.3 billion by 2032, CAGR 6.2%
19
Global NGS market for diagnostics was USD 4.2 billion in 2023, CAGR 14.1% to USD 12.5 billion by 2030
20
Europe point-of-care testing market valued at USD 9.8 billion in 2023, projected CAGR 6.3% through 2030
21
Clinical microbiology market size reached USD 7.6 billion in 2022, to USD 12.4 billion by 2030, CAGR 6.3%
22
Asia-Pacific IVD market was USD 22.3 billion in 2023, CAGR 6.7% to 2030
23
Global diagnostic labs market valued at USD 120.5 billion in 2023, expected USD 200.8 billion by 2032, CAGR 5.8%
24
U.S. immunoassay market size was USD 15.2 billion in 2022, CAGR 6.1% to USD 24.7 billion by 2030
25
The urinalysis market reached USD 1.4 billion in 2023, projected to USD 2.1 billion by 2030, CAGR 5.9%
26
Global companion diagnostics market was USD 7.8 billion in 2022, CAGR 12.3% to USD 18.9 billion by 2030
27
Latin America diagnostic imaging market valued at USD 3.1 billion in 2023, CAGR 5.2% to 2030
28
Middle East & Africa IVD market size was USD 4.5 billion in 2023, expected CAGR 7.4% through 2030
29
The cardiac biomarkers market hit USD 32.1 billion in 2023, to USD 48.7 billion by 2030, CAGR 6.1%
30
Global blood glucose monitoring system market valued at USD 11.3 billion in 2022, CAGR 8.2% to 2030
Interpretation
Market Size & Growth Interpretation
Despite humanity’s fondest wishes for health, the cold math of diagnostics reveals a booming industry where our collective need to know what ails us is projected to become, quite literally, a quarter-trillion-dollar question.
03 · Category
Regional Analysis27 stats
01
North America dominated the IVD market with 41% share in 2023 due to high adoption rates
02
Asia-Pacific IVD market grew fastest at 6.7% CAGR from 2023-2030, driven by China and India
03
Europe held 30% of global diagnostic imaging market in 2023, led by Germany and UK
04
U.S. accounted for 38.5% of North American clinical lab services market in 2023
05
China IVD market size reached USD 15.2 billion in 2023, CAGR 10.1% to 2030
06
India diagnostic labs market grew 12.4% YoY in 2023, valued at USD 18.7 billion
07
Germany molecular diagnostics market was EUR 2.1 billion in 2023, 9.3% CAGR projected
08
Japan point-of-care market hit USD 3.4 billion in 2022, driven by aging population
09
Brazil diagnostic imaging market valued at USD 1.8 billion in 2023, CAGR 6.8%
10
UK held 22% of European immunoassay market share in 2023
11
South Korea NGS diagnostics adoption reached 15% of oncology cases in 2023
12
Australia clinical chemistry market was AUD 1.2 billion in 2023, CAGR 5.1%
13
Mexico IVD market grew 8.2% in 2023 to USD 2.3 billion
14
France tissue diagnostics market valued at EUR 450 million in 2023
15
Saudi Arabia diagnostic labs market hit USD 1.1 billion in 2023, CAGR 9.5%
16
Canada hematology analyzers market was CAD 350 million in 2022
17
Russia PCR market grew despite sanctions, USD 450 million in 2023
18
UAE point-of-care testing market valued at USD 280 million in 2023, CAGR 11.2%
19
South Africa glucose monitoring devices market was ZAR 1.8 billion in 2023
20
Italy cardiac biomarkers testing reached EUR 320 million in 2023
21
Vietnam diagnostic imaging installations grew 15% YoY to 2023
22
Spain flow cytometry market valued at EUR 150 million in 2023
23
Turkey clinical microbiology labs processed 50M tests in 2023
24
Argentina urinalysis market hit USD 120 million in 2023, CAGR 7.1%
25
Netherlands companion diagnostics adoption at 28% in oncology by 2023
26
Thailand lab automation market grew to USD 250 million in 2023
27
Egypt diagnostic services market valued at EGP 12 billion in 2023
Interpretation
Regional Analysis Interpretation
While North America rests on its diagnostic laurels as the established heavyweight, the true pulse of the industry’s future is beating fastest in the rising clinics of Asia-Pacific, where breakneck growth in China and India signals a global shift from mere testing to mass accessibility.
More related reading
04 · Category
Technological Advancements25 stats
01
The adoption of AI in diagnostic imaging reached 25% of U.S. hospitals by 2023, improving accuracy by 15-20%
02
Next-generation sequencing (NGS) throughput increased 100-fold from 2015 to 2023, enabling whole-genome sequencing under USD 600
03
Point-of-care ultrasound devices reduced diagnostic time by 40% in emergency settings as per 2022 studies
04
Digital pathology slide scanners achieved 99.5% concordance with traditional microscopy in 2023 validations
05
CRISPR-based diagnostics detected SARS-CoV-2 in 15 minutes with 95% sensitivity in 2023 field trials
06
Liquid biopsy ctDNA assays improved early cancer detection sensitivity to 87% from 70% in 2020, per 2023 meta-analysis
07
Wearable biosensors for continuous glucose monitoring achieved 92% MARD accuracy in 2023 Dexcom G7 trials
08
Multiplex immunoassay panels tested 50+ biomarkers simultaneously, reducing sample volume by 70% in 2022
09
3D mammography (tomosynthesis) reduced false positives by 15% and recall rates by 37% in screening, 2023 data
10
Single-cell RNA sequencing resolved tumor heterogeneity in 95% of cases, advancing precision oncology in 2023
11
Photon-counting CT scanners improved spatial resolution to 0.2mm and reduced radiation by 30% in 2023 pilots
12
Microfluidic chips enabled portable PCR with 98% specificity for TB diagnosis in low-resource settings, 2022 WHO report
13
AI algorithms for ECG analysis detected AFib with 97% accuracy vs. 82% cardiologists in 2023 Apple Heart Study follow-up
14
Spatial transcriptomics mapped gene expression at 1μm resolution, revolutionizing pathology in 2023
15
Biosensor-based rapid antigen tests achieved 94% sensitivity for influenza A/B in 2023 Quidel studies
16
Robotic automation in labs processed 10,000 samples/day with 99.9% uptime in 2023 implementations
17
Mass spectrometry proteomics identified 5,000+ proteins/sample, up from 2,000 in 2020, per 2023 benchmarks
18
Wireless capsule endoscopy visualized 90% small bowel with AI lesion detection boosting yield by 25%, 2023
19
Quantum dot-enhanced lateral flow assays improved LOD to 1 pg/mL for troponin, 2023 research
20
Federated learning in radiology AI trained on 1M+ images across hospitals without data sharing, 2023
21
Organ-on-chip models predicted drug toxicity with 85% accuracy vs. 60% animal models in 2023 trials
22
Hyperspectral imaging differentiated skin lesions with 96% accuracy in 2023 dermatology studies
23
Nanopore sequencing enabled real-time pathogen ID in 2 hours with 99% accuracy, 2023 Oxford Nanopore data
24
Augmented reality guided biopsies improved precision by 28% in prostate cancer procedures, 2023
25
Blockchain-secured EHRs reduced diagnostic errors from data mismatches by 40% in 2023 pilots
Interpretation
Technological Advancements Interpretation
While these stunning statistics showcase a diagnostic revolution marching at a blistering pace—from AI outreading cardiologists to labs becoming robotic fortresses of efficiency—the profound takeaway is that medicine is finally shifting from a reactive art of educated guesses to a precise science of definitive, personalized, and astonishingly swift answers.
05 · Category
Trends & Projections24 stats
01
The IVD market is projected to reach USD 125.3 billion by 2030 at 3.9% CAGR amid rising chronic diseases
02
Point-of-care diagnostics expected to grow to USD 68.7 billion by 2030, driven by home testing kits, CAGR 5.7%
03
Molecular diagnostics market forecasted at USD 32.4 billion by 2030, CAGR 10.2% due to NGS and PCR advances
04
Global diagnostic imaging market to hit USD 55.2 billion by 2030, CAGR 5.1% with AI integration
05
Lab services market projected to USD 250 billion by 2030 globally, CAGR 6.2% from telemedicine
06
NGS clinical diagnostics to grow at 21.7% CAGR to USD 22.1 billion by 2028
07
Companion diagnostics market expected USD 18.9 billion by 2030, CAGR 12.3% with personalized medicine
08
Digital pathology market to reach USD 12.5 billion by 2032, CAGR 13.1% via cloud AI platforms
09
Remote diagnostics via telehealth projected to account for 30% of testing by 2030
10
Liquid biopsy market forecasted at USD 8.5 billion by 2030, CAGR 16.4% for non-invasive cancer screening
11
AI in diagnostics expected to add USD 150-250 billion annual value by 2026 through efficiency gains
12
Home-based diagnostics market to grow at 8.9% CAGR to USD 45 billion by 2030, post-COVID shift
13
Wearables for vital signs monitoring projected 25% penetration in chronic disease patients by 2030
14
CRISPR diagnostics market to explode to USD 5.2 billion by 2030, CAGR 24.3% for rapid pathogen ID
15
Oncology diagnostics segment to hold 35% of IVD market by 2030, driven by immuno-oncology
16
Lab-on-chip devices market projected USD 4.1 billion by 2030, CAGR 14.2% miniaturization trend
17
Biosimilars testing to drive 15% annual growth in protein analytics to 2030
18
Multi-omics integration in diagnostics expected in 40% of precision medicine by 2030
19
Sustainable diagnostics with green reagents to capture 20% market share by 2030
20
Infectious disease testing post-pandemic steady at 25% of IVD revenue through 2030
21
Diabetes diagnostics to grow at 7.5% CAGR to USD 28 billion by 2030 globally
22
Regulatory approvals for AI diagnostics rose 300% from 2020-2023, projected 50/year by 2030
23
Direct-to-consumer genetic testing market to USD 8.8 billion by 2030, CAGR 13.6%
24
Cardiac diagnostics influenced by wearables to reach USD 55 billion by 2030, CAGR 6.8%
Interpretation
Trends & Projections Interpretation
The sheer volume of these projections reveals we are not merely funding healthier futures but essentially building a multi-trillion-dollar health intelligence infrastructure, where every lab, home, and wearable becomes a front in the data-driven war against disease.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Daniel Varga. (2026, February 13). Diagnostic Testing Industry Statistics. Gitnux. https://gitnux.org/diagnostic-testing-industry-statistics
MLA
Daniel Varga. "Diagnostic Testing Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/diagnostic-testing-industry-statistics.
Chicago
Daniel Varga. 2026. "Diagnostic Testing Industry Statistics." Gitnux. https://gitnux.org/diagnostic-testing-industry-statistics.
Sources & references
34 datasets cited across this report · attribution is report-level